ABBISKO Trademark

Trademark Overview


On Tuesday, December 12, 2023, a trademark application was filed for ABBISKO with the United States Patent and Trademark Office. The USPTO has given the ABBISKO trademark a serial number of 79397370. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 12, 2024. This trademark is owned by Abbisko Therapeutics Co., Ltd. The ABBISKO trademark is filed in the Pharmaceutical Products category with the following description:

Drugs for medical purpose, namely, tumor inhibitors; Drugs for medical purpose, namely, for treating malignant tumors; Chemical preparations for pharmaceutical purposes for treating cancer; Biochemical drug, namely, pharmaceutical preparation for the treatment of cancer; Medicines for human use for the treatment of malignant tumors and achondroplasia; Medicinal solutions for injection for the treatment of cancer; Capsules for pharmaceutical purposes for the treatment of malignant tumors; Pharmaceutical preparations in the nature of immunosuppressants for fighting disease and infection; Pharmaceutical preparations for tumor immunotherapy; Chemical preparations for medical purpose for the treatment of malignant tumors; Tablets for the treatment of malignant tumors; Biological preparations for medical purpose for the treatment of malignant tumors
abbisko

General Information


Serial Number79397370
Word MarkABBISKO
Filing DateTuesday, December 12, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, November 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 12, 2024

Trademark Statements


Description of MarkThe mark consists of the stylized wording "ABBISKO".
Goods and ServicesDrugs for medical purpose, namely, tumor inhibitors; Drugs for medical purpose, namely, for treating malignant tumors; Chemical preparations for pharmaceutical purposes for treating cancer; Biochemical drug, namely, pharmaceutical preparation for the treatment of cancer; Medicines for human use for the treatment of malignant tumors and achondroplasia; Medicinal solutions for injection for the treatment of cancer; Capsules for pharmaceutical purposes for the treatment of malignant tumors; Pharmaceutical preparations in the nature of immunosuppressants for fighting disease and infection; Pharmaceutical preparations for tumor immunotherapy; Chemical preparations for medical purpose for the treatment of malignant tumors; Tablets for the treatment of malignant tumors; Biological preparations for medical purpose for the treatment of malignant tumors

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 13, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAbbisko Therapeutics Co., Ltd
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCN

Party NameAbbisko Therapeutics Co., Ltd
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCN

Trademark Events


Event DateEvent Description
Thursday, June 13, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, June 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 14, 2024APPLICATION FILING RECEIPT MAILED
Thursday, July 11, 2024ASSIGNED TO EXAMINER
Monday, July 29, 2024NON-FINAL ACTION WRITTEN
Tuesday, July 30, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, July 30, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, August 10, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, August 10, 2024REFUSAL PROCESSED BY MPU
Saturday, August 10, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, August 10, 2024REFUSAL PROCESSED BY MPU
Sunday, September 1, 2024REFUSAL PROCESSED BY IB
Friday, September 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 15, 2024REFUSAL PROCESSED BY IB
Tuesday, October 1, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 23, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED